AEON Biopharma Gestione
Gestione criteri di controllo 2/4
AEON Biopharma's CEO is Marc Forth, appointed in Dec 2019, has a tenure of 4.92 years. total yearly compensation is $3.98M, comprised of 13.8% salary and 86.2% bonuses, including company stock and options. directly owns 0.18% of the company’s shares, worth $61.56K. The average tenure of the management team and the board of directors is 3.3 years and 1.4 years respectively.
Informazioni chiave
Marc Forth
Amministratore delegato
US$4.0m
Compenso totale
| Percentuale dello stipendio del CEO | 13.8% |
| Mandato del CEO | 4.9yrs |
| Proprietà del CEO | 0.2% |
| Durata media del management | 3.3yrs |
| Durata media del Consiglio di amministrazione | 1.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$306m |
| Mar 31 2024 | n/a | n/a | -US$137m |
| Dec 31 2023 | US$4m | US$550k | -US$385m |
| Sep 30 2023 | n/a | n/a | -US$45m |
| Jun 30 2023 | n/a | n/a | -US$78m |
| Mar 31 2023 | n/a | n/a | -US$66m |
| Dec 31 2022 | US$5m | US$550k | -US$53m |
| Sep 30 2022 | n/a | n/a | -US$25m |
| Jun 30 2022 | n/a | n/a | -US$27m |
| Mar 31 2022 | n/a | n/a | -US$61m |
| Dec 31 2021 | n/a | n/a | -US$56m |
| Sep 30 2021 | n/a | n/a | -US$58m |
| Jun 30 2021 | n/a | n/a | -US$54m |
| Mar 31 2021 | n/a | n/a | -US$17m |
| Dec 31 2020 | US$3m | US$524k | -US$50m |
Compensazione vs Mercato: Marc's total compensation ($USD3.98M) is above average for companies of similar size in the US market ($USD655.65K).
Compensazione vs guadagni: Marc's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Marc Forth (53 yo)
4.9yrs
Mandato
US$3,982,378
Compensazione
Mr. Marc Forth serves as Chief Executive Officer at AEON Biopharma, Inc., since December 2019 and also serves as its Principal Financial Officer since May 17, 2024 and serves as its President. Prior to AEO...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Principal Financial Officer | 4.9yrs | US$3.98m | 0.18% $ 61.6k | |
| Executive VP | 3.3yrs | US$1.40m | 0.052% $ 17.9k | |
| Chief Medical Officer | 3.4yrs | US$1.65m | 0.064% $ 22.1k | |
| Principal Accounting Officer | less than a year | Nessun dato | 0% $ 0 |
3.3yrs
Durata media
46yo
Età media
Gestione esperta: AEON's management team is considered experienced (3.3 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Principal Financial Officer | 1.4yrs | US$3.98m | 0.18% $ 61.6k | |
| Independent Director | 1.4yrs | US$197.87k | 5.73% $ 2.0m | |
| Independent Director | 1.4yrs | US$198.86k | 0% $ 0 | |
| Chairman | 7.8yrs | US$862.46k | 0.11% $ 38.5k | |
| Independent Director | 1.4yrs | US$216.91k | 0% $ 0 | |
| Director | less than a year | Nessun dato | Nessun dato |
1.4yrs
Durata media
70yo
Età media
Consiglio di amministrazione esperto: AEON's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.